[What are the major parameters to follow for the management anaemia in dialysis patients? What is the frequency of survey and what are the guidelines?].
Anaemia treatment in dialysis population is a permanent preoccupation for nephrologists. The erythropoiesis stimulating agents have disrupted its management. The international guidelines define the different parameters to follow and the periodicity of survey. It allows us to harmonize our practice and guaranty an optimization of anaemia treatment in the dialysis population.
Leray-Moragues
Hélène
H
Service de néphrologie, dialyse, soins intensifs, CHRU Lapeyronie, 34295 Montpellier 05, France. h-leray_moragues@chu-montpellier.fr
Canaud
Bernard
B
D000740:Anemia / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D003140:Communicable Disease Control; D015314:Dialysis Solutions / Q000592:standards; D004920:Erythropoiesis; D006801:Humans; D006961:Hyperparathyroidism / Q000517:prevention & control; D007249:Inflammation / Q000517:prevention & control; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*
D015314:Dialysis Solutions